急性缺血性卒中患者接受阿替普酶与替奈普酶治疗的工作流程与结局的性别分析
AcT试验的事后分析比较了1577例接受静脉溶栓的急性缺血性卒中患者在4.5小时内的性别差异,其中女性755例(47.9%)。女性年龄更大、卒中更严重且大血管闭塞比例更高;校正年龄、卒中严重程度和闭塞部位后,两性结局无差异,工作流程质量指标也无性别差异。
要点
- 女性年龄更大、卒中更严重且大血管闭塞比例更高。
- 未校正时女性功能独立率更低、死亡率更高。
- 校正预后因素后两性结局无差异,工作流程无性别差异。
核心结论
- 年龄、卒中严重程度和闭塞部位等预后因素的差异很大程度上解释了女性功能依赖和死亡率更高。
- 工作流程质量指标未见明显性别差异。
- 鉴于AcT试验已整合入临床实践,这些结果令人放心,在参与研究的加拿大各中心急性卒中管理中未见明显重大性别偏倚。
研究设计与样本
- AcT试验是一项多中心、注册链接的随机非劣效性试验,比较替奈普酶(0.25 mg/kg)与阿替普酶(0.9 mg/kg)在发病4.5小时内的急性缺血性卒中患者。
- 本分析为AcT试验的事后分析,共纳入1577例接受静脉溶栓的患者(2019-2022年),其中女性755例(47.9%)。
- 比较基线特征、工作流程时间、成功再灌注(扩展脑梗死溶栓评分≥2b)、症状性颅内出血、90天功能独立(改良Rankin量表评分0-1)和90天死亡率,并按性别分组。
- 采用混合效应回归分析校正年龄、卒中严重程度和闭塞部位。
主要发现
- 女性中位年龄77岁(68-86) vs 男性70岁(59-79)。
- 女性严重卒中(美国国立卫生研究院卒中量表评分>15)比例32.4% vs 男性24.9%。
- 女性大血管闭塞比例28.7% vs 男性21.5%。
- 所有工作流程时间在两性间相当。
- 女性功能独立率31.7% vs 男性39.8%(未校正相对危险度0.80,95%CI 0.70-0.91);女性死亡率17.7% vs 男性13.3%(未校正相对危险度1.33,95%CI 1.06-1.69)。
关键数值与推荐
- 成功再灌注定义为扩展脑梗死溶栓评分≥2b。
- 功能独立定义为改良Rankin量表评分0-1。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Understanding sex differences in stroke care is important in reducing potential disparities. Our objective was to explore sex differences in workflow efficiency, treatment efficacy, and safety in the AcT trial (Alteplase Compared to Tenecteplase). METHODS: AcT was a multicenter, registry-linked randomized noninferiority trial comparing tenecteplase (0.25 mg/kg) with alteplase (0.9 mg/kg) in acute ischemic stroke within 4.5 hours of onset. In this post hoc analysis, baseline characteristics, workflow times, successful reperfusion (extended Thrombolysis in Cerebral Infarction score ≥2b), symptomatic intracerebral hemorrhage, 90-day functional independence (modified Rankin Scale score, 0-1), and 90-day mortality were compared by sex. Mixed-effects regression analysis was used adjusting for age, stroke severity, and occlusion site for outcomes. RESULTS: Of 1577 patients treated with intravenous thrombolysis (2019-2022), 755 (47.9%) were women. Women were older (median, 77 [68-86] years in women versus 70 [59-79] years in men) and had a higher proportion of severe strokes (National Institutes of Health Stroke Scale score >15; 32.4% versus 24.9%) and large vessel occlusions (28.7% versus 21.5%) compared with men. All workflow times were comparable between sexes. Women were less likely to achieve functional independence (31.7% versus 39.8%; unadjusted relative risk, 0.80 [95% CI, 0.70-0.91]) and had higher mortality (17.7% versus 13.3%; unadjusted relative risk, 1.33 [95% CI, 1.06-1.69]). Adjusted analysis showed no difference in outcomes between sexes. CONCLUSIONS: Differences in prognostic factors of age, stroke severity, and occlusion site largely accounted for higher functional dependence and mortality in women. No sex disparities were apparent in workflow quality indicators. Given the integration of the AcT trial into clinical practice, these results provide reassurance that no major sex biases are apparent in acute stroke management throughout participating Canadian centers. REGISTRATION: URL: https://www.clinicaltrials.gov; Unique identifier: NCT03889249.
引用
- Kim DJ, Singh N, Catanese L, et al. Sex-Based Analysis of Workflow and Outcomes in Acute Ischemic Stroke Patients Treated With Alteplase Versus Tenecteplase. Stroke. 2024. PMID: 38174568. doi:10.1161/STROKEAHA.123.045320
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。